A Study to Test a New Fluid to Improve the Quality of Images Obtained by Using Sound Waves (Ultrasound) During Surgery
Phase NA Recruiting
15 enrolled
STOPOMP
Phase NA Recruiting
63 enrolled
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
Phase NA Recruiting
150 enrolled
PRECISE-BTN
Phase NA Recruiting
100 enrolled
ASSURE
Phase NA Recruiting
80 enrolled
A Phase 2/3,PSMA-T4, Prostate Cancer
Phase NA Recruiting
80 enrolled
Autologous Tumor-Infiltrating Lymphocyte (GT307) for Treatment of Patients With Solid Tumours
Phase NA Recruiting
18 enrolled
Autologous Tumor-Infiltrating Lymphocyte (GT307) for Treatment of Patients With Advanced Colorectal Cancer
Phase NA Recruiting
18 enrolled
Colonic
Phase NA Recruiting
20 enrolled
AURORA
Phase NA Recruiting
43 enrolled
SIGNAL-ER 101
Phase NA Recruiting
725 enrolled
Decentralized Clinical Trial of Effectiveness of EnergyPoints App in Cancer Survivors
Phase NA Recruiting
180 enrolled
Alpha Radiation Emitters Device (DaRT) in Combination With Check Point Inhibitor for the Treatment of Recurrent Unresectable or mHNSCC
Phase NA Recruiting
48 enrolled
Alpha Radiation Emitters Device (DaRT) for Target Treatments of Malignant Tumors
Phase NA Recruiting
100 enrolled
Alpha Radiation Emitters Device (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer
Phase NA Recruiting
30 enrolled
Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Glioblastoma
Phase NA Recruiting
10 enrolled
WATER IV PCa
Phase NA Recruiting
280 enrolled
INDIGO
Phase NA Recruiting
51 enrolled
The REBALANCE Study - a Prospective, Multicenter, Randomized, Pivotal Study of the May Health System
Phase NA Recruiting
195 enrolled
TARGET
Phase NA Recruiting
25 enrolled
PARC
Phase NA Recruiting
10 enrolled
LAPC
Phase NA Recruiting
30 enrolled
Anti-HER2 CAR-T Cell Injection in Patients With HER2-positive Advanced Malignant Solid Tumors
Phase NA Recruiting
30 enrolled
BA-004
Phase NA Recruiting
2,063 enrolled
Comparison Between Liquid-Based Cytology And Molecular Screening For Detecting Precursor Lesions and Cervical Cancer
Phase NA Recruiting
558 enrolled
SECURE
Phase NA Recruiting
137 enrolled
ARTIA-Pancreas
Phase NA Recruiting
134 enrolled
PT2
Phase NA Recruiting
35 enrolled
Feasibility Study of CBCT for IGRT in Cancer Patients
Phase NA Recruiting
50 enrolled
ANGEL
Phase NA Recruiting
2,706 enrolled
Evaluation of Clinical Efficacy of Augmented Reality (AR)-Based Breast Cancer Medical Imaging Solution (SKIA-Breast) Localization Method in Breast Cancer Patients
Phase NA Recruiting
94 enrolled
Bioequivalence Study of Paclitaxel for Injection (Albumin Bound) in Subjects With Breast Cancer
Phase NA Recruiting
24 enrolled
To Evaluate the Clinical Efficacy of Probiotics in Patients With the Breast Cancer
Phase NA Recruiting
100 enrolled
Supportive Care Intervention for Outpatient Stem Cell Transplant Patients
Phase NA Recruiting
90 enrolled
Stratagen Quantitative Prostate MRI Platform Pilot Study
Phase NA Recruiting
75 enrolled
Embrace Gyn
Phase NA Recruiting
70 enrolled
A Clinical Trial to Investigate the Safety and Efficacy of Papillex® on Abnormal Cervical Cells Caused by HPV.
Phase NA Recruiting
60 enrolled
Early Feasibility Study (EFS) of the 'CAROL' for Treatment of Lung Cancer Stage 1
Phase NA Recruiting
7 enrolled
Closing the GAPS: Guideline Adherence, Prevention and Surveillance in Hereditary Cancer
Phase NA Recruiting
100 enrolled
REMASTer: REcurrent Brain Metastases After SRS Trial
Phase NA Recruiting
261 enrolled
Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors
Phase NA Recruiting
122 enrolled
SY001 Targets Mesothelin in a Single-arm, Dose-increasing Setting in Subjects With Advanced Solid Tumors
Phase NA Recruiting
2 enrolled
Vitamin D, Epigallocatechin Gallate, D-chiro-inositol and Vitamin B6 in Uterine Fibroid
Phase NA Recruiting
60 enrolled
Feasibility Study for the SIRA-1000, SIRA® RFA Electrosurgical Device as an Adjunct to Breast Conserving Surgery
Phase NA Recruiting
10 enrolled
The Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia.
Phase NA Recruiting
9 enrolled
Galleri® in the Medicare Population.
Phase NA Recruiting
50,000 enrolled
A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning
Phase NA Recruiting
150 enrolled
ARTIA-Prostate
Phase NA Recruiting
132 enrolled
The Ailliance Post-Market Clinical Study
Phase NA Recruiting
1,000 enrolled
EQUIP
Phase NA Recruiting
450 enrolled